Incyte Corp (INCY)
72.41 -1.06 (-1.44%) 01/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 72.41 unch (unch) 16:41 ET
for Wed, Jan 22nd, 2025
Results
download Want to compare other data? Select FieldsSymbol | INCY | GMAB | MRNA | ||
Company | Incyte Corp | Genmab A/S ADR | Moderna Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 73.47 | 21.52 | 36.35 | ||
High | 73.55 | 21.52 | 41.09 | ||
Low | 71.97 | 20.96 | 36.00 | ||
Last | 72.41 | 20.97 | 38.50 | ||
Change | -1.06 | -0.83 | +2.61 | ||
% Change | -1.44% | -3.81% | +7.27% | ||
Volume | 1,136,992 | 920,644 | 16,607,178 | ||
20-Day Average Volume | 1,590,150 | 1,069,682 | 11,367,614 | ||
Previous Close | 73.47 | 21.80 | 35.89 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 70.99 | 21.20 | 39.35 | ||
20-Day Raw Stochastic | 67.73% | 45.28% | 38.63% | ||
20-Day Relative Strength | 52.26% | 47.20% | 45.18% | ||
Weighted Alpha | +22.22 | -28.15 | -64.84 | ||
Today's Opinion | 56% Buy | 96% Sell | 100% Sell | ||
Previous Opinion | 72% Buy | 64% Sell | 100% Sell | ||
Last Month's Opinion | 40% Buy | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.67% since 01/14/25 | -3.10% since 01/14/25 | +11.72% since 01/14/25 | ||
Low | 71.72 on 01/16/25 | 19.89 on 01/15/25 | 33.34 on 01/16/25 | ||
High | 73.98 on 01/21/25 | 21.85 on 01/21/25 | 41.09 on 01/22/25 | ||
1-Month | |||||
%Chg | +5.19% since 12/20/24 | +3.25% since 12/20/24 | -2.26% since 12/20/24 | ||
Low | 67.70 on 12/30/24 | 19.89 on 01/15/25 | 31.94 on 01/13/25 | ||
High | 75.04 on 01/07/25 | 22.27 on 01/07/25 | 48.92 on 01/07/25 | ||
3-Month | |||||
%Chg | +10.40% since 10/22/24 | -7.91% since 10/22/24 | -27.90% since 10/22/24 | ||
Low | 64.76 on 10/23/24 | 19.85 on 12/16/24 | 31.94 on 01/13/25 | ||
High | 83.95 on 11/08/24 | 23.47 on 11/11/24 | 57.69 on 10/29/24 | ||
6-Month | |||||
%Chg | +11.08% since 07/22/24 | -24.57% since 07/22/24 | -68.57% since 07/22/24 | ||
Low | 60.19 on 08/08/24 | 19.85 on 12/16/24 | 31.94 on 01/13/25 | ||
High | 83.95 on 11/08/24 | 28.56 on 07/31/24 | 125.68 on 07/30/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 14,153,995 | 14,426,542 | 13,811,118 | ||
Shares Outstanding, K | 192,650 | 661,768 | 384,818 | ||
Annual Sales | 3,695,650,000 | 2,392,030,000 | 6,848,000,000 | ||
Annual Net Income | 597,600,000 | 631,910,000 | -4,714,000,000 | ||
Last Quarter Sales | 1,137,870,000 | 816,600,000 | 1,862,000,000 | ||
Last Quarter Net Income | 106,460,000 | 186,610,000 | 13,000,000 | ||
60-Month Beta | 0.71 | 0.97 | 1.60 | ||
Per-Share Information | |||||
Most Recent Earnings | 1.07 on 10/29/24 | 0.29 on 11/06/24 | 0.03 on 11/07/24 | ||
Latest Earnings Date | 02/10/25 | 02/12/25 | 02/27/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 20.19 | 0.00 |